Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$550,252
-$64,674 QoQ
Shares Held
10,497
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#462
of 1,033 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tripletail Wealth Management, LLC holds $2,827,313 across 10 Drug Manufacturers - General names. GSK ranks #3 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
706 | $846,797 | |
| 2 | ABBV |
AbbVie Inc.
|
2,579 | $648,979 | |
| 3 | GSK |
GSK plc
This page
|
10,497 | $550,252 | |
| 4 | AMGN |
Amgen Inc
|
800 | $289,696 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 6 | NVS |
Novartis AG
|
790 | $123,808 | |
| 7 | JNJ |
Johnson & Johnson
|
260 | $66,032 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
376 | $21,665 |
All Filings in GSK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $550,252 | 10,497 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $614,926 | 11,142 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $570,923 | 11,642 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $502,468 | 11,642 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $450,892 | 11,742 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||